Dr. Wei Yang is currently an associate professor of surgery and biomedical sciences at Cedars-Sinai Medical Center, where he also previously served as the director of the Mass Spectrometry and Biomarker Discovery Core. In addition to his work at Cedars-Sinai Medical Center, Dr. Yang serves as an associate professor of medicine at the University of California. His research focuses on developing and applying leading-edge proteomics technologies to identify novel cancer biomarkers and clinically actionable anti-cancer drug targets as well as their mechanisms of action. Dr. Yang’s research is funded by the National Cancer Institute (NCI) and the Department of Defense (DoD). He is a reviewer for over 30 prestigious scientific journals such as Nature Communications and Theranostics.